News

WEBINAR: Gene Editing Data Analysis - Overcome challenges in executing, evaluating, and reporting complex genome editing data

RECORDING NOW AVAILABLE:  This webinar is for scientists, clinical researchers and regulatory professionals involved in the design, execution, and analysis of gene editing experiments. 
Read More

Want to see how any researcher can perform fast and scalable NGS data analysis?

Check out this video of Catalytic's Karly Sindy showing how we solve data analysis challenges for our life sciences customers.   With Catalytic's suite of data analytic tools, researchers can now scale and process data loads in hours versus weeks creating huge productivity gains for our customers.  
Read More

Introducing Magpie - a Multiplexed Automated Gene Editing Evaluation Pipeline

WATCH DEMO VIDEO: Companies involved in the design, execution and analysis of gene editing experiments face significant challenges around both data analytics and meeting FDA safety requirements.  Catalytic built ‘Magpie’ – a Multiplexed Automated Gene Editing Evaluation Pipeline to enable companies to evaluate the outcome of their experiments at scale and in a manner that meets strict regulatory and safety guidelines. 
Read More

Pharma's broken business model - Part 2: Scraping the barrel in drug discovery

Part 2 of Kelvin Stott’s great work on pharma declining R&D ROI. Why aren’t we finding and drugging new therapeutic targets more efficiently?
Read More

Pharma's broken business model - Part 1: An industry on the brink of terminal decline

Part one of a very insightful analysis by Kelvin Stott showing Pharmaceutical IRR will hit 0% by 2020. Why isn’t translational success rising given better research methodologies and richer datasets?
Read More

Spearheading Innovation in Life Sciences Featured By CIO Review Magazine

We proudly announce Catalytic Data Science is featured as the cover story and named by CIO Review Magazine as one of “20 Most Promising Data Analytics Solution Providers of 2018.”    
Read More

Part 3:  Achieve Your Milestones Faster With a Life Sciences R&D Cloud Platform

In part two of this series, we demonstrated that knowledge products derive their value by possessing unique insights about a therapeutic target, disease or new molecular entity.  Great information architecture is a fundamental building block that enables a company to engineer its insight production process and accelerate the creation of valuable knowledge products.  In this post, we will describe how a life sciences R&D cloud platform can accelerate turning unknowns into knowns by significantly increasing the amount of data and information that a company can process.
Read More

Part 2:  Achieve Your Milestones Faster With a Life Sciences R&D Cloud Platform

In part one of this series we showed that life sciences companies must first sell knowledge products to corporate partners, regulators and investors well before they sell new therapeutic products to patients.  Implementing a life sciences R&D cloud platform can reduce the time required to achieve key milestones, increase, increase organizational efficiency and serve as a source of competitive differentiation.  This post will describe how engineering information architectures can accelerate the process of creating unique insights that enable companies to monetize their knowledge.  
Read More

Part 1: Achieve Your Milestones Faster With a Life Sciences R&D Cloud Platform

This post is part one in a series that will examine how creating and implementing a life sciences R&D cloud platform can reduce time required to achieve key milestones, increase organizational efficiency, reduce development time, streamline workflows and communication and serve as a source of competitive differentiation. 
Read More

Welcome to the Catalytic blog!

Hello, life sciences community, and welcome to the Catalytic Blog. At Catalytic, we’re working hard to build a new kind of platform that makes researchers more productive and life sciences companies more successful. We will be writing about why building technology for life sciences companies is so meaningful and why it’s so challenging.
Read More